| This week's sponsor is Premier Research. | | | Tips for Achieving the Most Success in Acute-Pain Drug Trials
Sponsors studying treatments for acute pain boost their odds of success when they optimize conduct of early trials. Read our white paper for helpful tips on study design, assessment, and operations. Premier Research. It's what we do. Best. |
Featured Story | | | Thursday, September 14, 2017 Moderna has once again dumped a whole load of updates as it looks to take an AstraZeneca-partnered medication into phase 2 and start on I-O, while making changes to its venture model. |
|
|
| This week's sponsor is Fierce Innovation Awards. | | | Now Accepting Applications! Deadline: Friday, October 20th
Does your product/service have the potential to transform the biotech or pharma industry? This is your chance to submit an application and have your solution reviewed by our expert panel of judges. Apply today! |
Top Stories Thursday, September 14, 2017 Atopic dermatitis is being pitched as a big new market for immune-modifying drugs, but is a tough drug development prospect—as Vanda Pharmaceuticals has just found out. Thursday, September 14, 2017 Bristol-Myers Squibb has paid Halozyme $105 million upfront to access drug delivery technology. The agreement positions Bristol-Myers to develop subcutaneous formulations of molecules against PD-1 and 10 other immuno-oncology targets. Monday, September 11, 2017 When it comes to healthcare we know that consumers actively participate in social media to seek information and find support. More than 40% say that information from social media affects how they cope with a chronic condition, their approach to diet and exercise, the physician they select and even their decision to seek a second opinion. Thursday, September 14, 2017 A cadre of SGLT2 medications may have beaten Sanofi and Lexicon to that fast-growing market, but they aim to carve out a place for their experimental drug sotagliflozin in type 1 diabetes. Based on data parsed at EASD, the companies plan to file for FDA approval in early 2018. Thursday, September 14, 2017 Otonomy is hunkering down after a phase 3 wipeout devastated its near-term prospects. The ear disease firm is laying off one-third of its noncommercial staff and hitting pause on its remaining pipeline programs. Thursday, September 14, 2017 Looking to boost its drug offerings, U.K. CRO Clinigen has paid £150.3 million (around $200 million) to buy out Quantum Pharma. Thursday, September 14, 2017 Lymphatic vessels are tiny structures that drain fluid from the body—but they are also blamed for carrying cancer cells from the primary tumor to other locations in the body. Now a research team led by the University of Chicago has discovered that these vessels can enable immune cells to kill cancer cells. Thursday, September 14, 2017 AstraZeneca’s Farxiga is already battling it out with its SGLT2 rivals in Type 2 diabetes. But it may have a future in another field, too, if data from a new Type 1 study can expand its use. Resources Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. 2nd Strategic Partnerships for Drug Repurposing October 26-27, 2017 | Boston, MA Compliance Certificate and Training for Life Sciences Professionals October 9 -12, 2017 | Newark, NJ CBI’s MedComm 2017 Conference October 26-27, 2017 | San Francisco, CA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London 11th Digital Pharma East October 3-6, 2017 | Philadelphia, PA Don't Miss This Opportunity | Life Sciences Innovation Awards Application Deadline: Friday, October 20 at midnight EST Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 